Calypte Biomedical Corp (CBMC) financial statements (2020 and earlier)

Company profile

Business Address 5000 HOPYARD ROAD, SUITE 480
PLEASANTON, CA 94588
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0
Cash and cash equivalents0
Receivables0
Inventory, net of allowances, customer advances and progress billings0
Inventory0
Prepaid expense0
Total current assets:0
Noncurrent Assets
Property, plant and equipment0
Intangible assets, net (including goodwill)2
Intangible assets, net (excluding goodwill)2
Other noncurrent assets0
Total noncurrent assets:2
TOTAL ASSETS:2
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2
Employee-related liabilities0
Other undisclosed accounts payable and accrued liabilities2
Debt0
Other undisclosed current liabilities1
Total current liabilities:3
Noncurrent Liabilities
Other undisclosed noncurrent liabilities4
Total noncurrent liabilities:4
Total liabilities:7
Temporary equity, carrying amount4
Stockholders' equity
Stockholders' equity attributable to parent(5)
Common stock16
Additional paid in capital160
Accumulated other comprehensive loss(0)
Accumulated deficit(181)
Other undisclosed stockholders' equity(4)
Total stockholders' equity:(9)
TOTAL LIABILITIES AND EQUITY:2

Income statement (P&L) ($ in millions)

12/31/2012
Revenues
(Revenue, Net)
0
Cost of revenue
(Cost of Goods and Services Sold)
(0)
Gross profit:0
Operating expenses(1)
Other undisclosed operating income0
Operating loss:(1)
Interest and debt expense(0)
Other undisclosed income from continuing operations before equity method investments, income taxes0
Net loss available to common stockholders, diluted:(1)

Comprehensive Income ($ in millions)

12/31/2012
Net loss:(1)
Comprehensive loss, net of tax, attributable to parent:(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: